Screening method to evaluate point-of-care human chorionic gonadotropin (hcg) devices for susceptibility to the hook effect by hcg β core fragment: Evaluation of 11 devices

Clinical Chemistry

Volumn 60, Issue 4, 2014, Pages 667-674

  Nerenz, Robert D ^a   Song, Haowei ^a   Gronowski, Ann M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CONCENTRATION (PARAMETERS); FALSE NEGATIVE RESULT; FEMALE; GYNECOLOGICAL AND OBSTETRIC DIAGNOSTIC DEVICE; HEALTH CARE PERSONNEL; HUMAN; POINT OF CARE TESTING; PREGNANCY RAPID TEST; PREGNANCY TEST; SCREENING TEST; SP HCG COMBO RAPID TEST;

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; POINT-OF-CARE SYSTEMS; PREGNANCY; PREGNANCY TESTS;

EID: 84897504380     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.217661     Document Type: Article

References (14)

1. Cole LA, Kardana A, Park SY, Braunstein GD. The deactivation of hCG by nicking and dissociation. J Clin Endocrinol Metab 1993;76:704-10. (Pubitemid 23086492)
2. Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the betasubunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38:1981-7.
3. Kovalevskaya G, Birken S, Kakuma T, O'Connor JF. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG. J Endocrinol 1999;161:99-106. (Pubitemid 29170196)
4. Kato Y, Braunstein GD. Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy. J Clin Endocrinol Metab 1988;66:1197-201.
5. McChesney R, Wilcox AJ, O'Connor JF, Weinberg CR, Baird DD, Schlatterer JP, et al. Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy. Hum Reprod 2005;20:928-35. (Pubitemid 40667837)
6. Stenman U-H, Tiitinen, Alfthan H, Valmu, L. The classification, functions and clinical use of different isoforms of hCG. Hum Reprod 2006;12:769-84. (Pubitemid 44605514)
7. Gronowski AM, Cervinski M, Stenman UH, Woodworth A, Ashby L, Scott MG. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clin Chem 2009;55:1389-94.
8. Klee GG. Interferences in hormone immunoassays. Clin Lab Med 2004;24:1-18. (Pubitemid 38638106)
9. Maderbacher S, Berger P. Antibodies and immunoassays. Methods 2000;21:41-50. (Pubitemid 32896769)
10. de Medeiros SF, Amato F, Matthews CD, Norman RJ. Molecular heterogeneity of the β-core fragment of human chorionic gonadotropin. J Endocrinol 1993;139:519-32.
11. Nerenz RD, Gronowski AM. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment. Clin Chem 2013;59:1672-4.
12. Gronowski AM, Powers M, Stenman U-H, Ashby LA, Scott M. False negative results from point-ofcare qualitative devices due to excess hCG beta core fragment varies with device lot number. Clin Chem 2009;55:1885-6.
13. Sigel CS, Grenache DG. Detection of unexpected isoforms of human chorionic gonadotropin by qualitative tests. Clin Chem 2007;53:989-90. (Pubitemid 46744260)
14. Berger P, Paus E, Hemken PM, Sturgeon C, Stewart WW, Skinner JP, Harwick LC et al. Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop. Tumor Biol 2013;34:4033-57.